Community-phenotype-methicillin-resistant staphylococcus aureus infections: A retrospective chart review of outcomes after treatment with daptomycin

Clinical Therapeutics

Volumn 29, Issue 11, 2007, Pages 2440-2447

  Katz, David E ^a   Martone, William J ^a  

^a CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

community; daptomycin; efficacy; methicillin resistant Staphylococcus aureus

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN;

ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL ASSESSMENT; COMMUNITY; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; ENDOCARDITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PHENOTYPE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DAPTOMYCIN; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 37349055048     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.11.019     Document Type: Article

References (16)

1. Schramm G., Johnson J., Doherty J., et al. Increasing incidence of sterilesite infections due to non-multidrug-resistant, oxacillin-resistant Staphylococcus aureus among hospitalized patients. Infect Control Hosp Epidemiol 28 (2007) 95-97
2. Moran G., Amii R., Abrahamian F., and Talan D. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 11 (2005) 928-930
3. Crum N., Lee R., Thornton S., et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 119 (2006) 943-951
4. Naimi T., LeDell K., Como-Sabetti K., et al. Comparison of community and health care associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
5. Moellering Jr. R. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med 144 (2006) 368-370
6. Gonzalez B., Rueda A., Shelburne III S., et al. Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of health-care-associated infection. Infect Control Hosp Epidemiol 27 (2006) 1051-1056
7. Davis S., Rybak M., Amjad M., et al. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 27 (2006) 1025-1031
8. Maree C., Daum E., Boyle-Vavra S., et al. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infec Dis 13 (2007) 236-242
9. Arbeit R., Maki D., Tally F., et al., the Daptomycin 98-01 and 99-01 Investigators. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 38 (2004) 1673-1681
10. Fowler Jr. V., Boucher H., Corey G., et al., the S. aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355 (2006) 653-665
11. Cubicin (daptomycin for injection) [pre-scribing information]. Lexington, Mass: Cubist Pharmaceuticals, Inc; 2006.
12. The National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
13. Vandenesch F., Naimi T., Enright M., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
14. The Centers for Disease Control and Prevention. Community-associated MRSA information for clinicians [CDC Web site], http://www.cdc.gov/ncidod/dhqp/ar_mrsa ca clinicians.html.
15. LaPlante K., Rybak M., and Amjad M. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community and hospital-associated methicillin-resistant Staphylococcus aureus. Pharmacotherapy 27 (2007) 3-10
16. Tsuji B., Rybak M., and Cheung C. Community and health care associated methicillin-resistant Staphylococcus aureus: A comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis. 58 (2007) 41-47